Cellular and Molecular Gastroenterology and Hepatology · 2016 · 50 citations · 39 references
MedicineInternal MedicineMolecular GeneticsHepatologyImmunogeneticsInnate ImmunityChronic Liver DiseaseHepatic ImpairmentHepatic PathologyLiver DiseaseLiver Function TestsMetabolic Liver DiseaseAlagille SyndromeAlas2 Gene MutationsGenetic Liver DiseaseLiver Disease Severity Criteria
BACKGROUND & AIMS: , resulting in bile duct paucity, cholestasis, cardiac disease, and other features. Liver disease severity in Alagille syndrome is highly variable, however, factors influencing the hepatic phenotype are unknown. We hypothesized that genetic modifiers may contribute to the variable expressivity of this disorder. METHODS: mutations, comparing patients with mild vs severe liver disease, followed by functional characterization of a candidate locus. RESULTS: -null mouse livers showed increased microvessels in the portal regions of adult mice. We also showed that thrombospondin 2 interacts with NOTCH1 and NOTCH2 and can inhibit JAG1-NOTCH2 interactions. CONCLUSIONS: as a plausible candidate genetic modifier of liver disease severity in Alagille syndrome.
39
An integrated encyclopedia of DNA elements in the human genome
An integrated map of genetic variation from 1,092 human genomes
The International HapMap Project
Richard A. Gibbs, John W. Belmont, Paul Hardenbol et al. · Nature · 2003 · 6.2K citations · Full text